News & Press: Breaking News

Registration Open for Pre-Conference Workshop at ISCT Europe 2015 Regional Meeting

Monday, August 10, 2015  
Share |

MSC & Cancer: Trojan Horses for Novel Cancer Therapeutics or Fast Food For Tumors

Wednesday September 23rd
1300 - 1900
Hotel Barceló Sevilla Renacimiento

Workshop Co-Chairs: Khalid Shah, MS, PhD & Massimo Dominici, MD

 

Objectives of the Workshop:

  1. Highlight the roles of MSC in tumor microenvironment and in cancer immunity
  2. Describe the role of naive MSC as Tumor Promoting/Suppressing agents in in vivo models
  3. Dissect the possible technical limitations/advantages (in vitro and in vivo) in addressing the pro- and anti-tumorigenic functions of MSC in pre-clinical settings
  4. Present MSC-gene modified models in the context of several cancer types (brain, lungs, pancreas, sarcomas and more)
  5. Promote potential interactions between relevant investigators in the field
  6. Build academic-industry partnerships for MSC based approaches in cancer patients

The workshop is divided into 3 sessions:

  • SESSION 1: HAMBURGERS OR TROJAN HORSES: THAT IS THE PROBLEM
  • SESSION 2: THE TRAIL TO CLINIC
  • SESSION 3: THE EARLY CLINICAL EVIDENCES

Confirmed Speakers and Tentative Topics:

  • Antoine E Karnoub, PhD (USA): Role of MSC-regulated micRNAs in tumor progression
  • Julia Houthuijzen, MSc (Netherlands)Role of MSC in anti-cancer drug resistance and tumor progression
  • Giulio Alessandri, PhD (Italy): MSC loaded with traditional drugs for tumor therapy
  • Lucia Kucerova, PhD (Slovacchia): MSC and pro-drugs activators in cancers
  • Giulia GrisendiPhD (Italy): MSC in pancreatic adenocarcinoma and sarcoma
  • Daniel Weiss, MD, PhD (USA): MSC in deathly lung cancers: the mesothelioma model
  • Khalid Shah, MS, PhD (USA): Receptor targeted and encapsulated MSC for tumors in the brain
  • Samuel Janes, MBBS, MRCP, MSc, PhD (UK): MSC towards the clinic for lung cancers

For program and registration information click here.


© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.